Ocular Disease:posterior Flashcards
Hruby Lens
◦ Indications: nonctonact examination of the optic disc, macula, posterior pole, and central vitreous
◦ Interpretation: provides a stereoscopic, erect, and magnified image
Three mirror lens indication
examination of the retina extending from the optic disc to the ora seratta. Performed in patients with peripheral retinal concerns such as peripheral vascular disease, history of blunt trauma, and those at risk or with symptoms of a retinal detachment
3 mirror lens interpretation
provides a stereoscopic, reversed, and magnified image of the retina 180 degrees away from he position of the mirror.
Trapezoid mirror on 3 mirror
73 degrees
Evaluate equator
Square mirror on three mirror
67 degrees
Used to eval the area between the anterior equator and the ora
Bullet mirror on 3 mirror
59 degrees
Anteiror chamber angle and the ora
Are 3 mirror views displaced laterally?
No
Indications of 78/90D lens
routine posterior segment evaluations. Easier to use than the Hruby lens and the three mirror. Image magnification and FOV are directly proportional to the pupil diameter and the dioptric power of the lens
Image in 78/90D
real, inverted, and reversed magnified image
Indications of BIO
routine comprehensive evaluation and similar indications as three mirror evaluation
Image in BIO
provides a real image that is magnified, reversed L-R, inverted top to bottom, and located between the examiner and the condensing lens
Red free filter
‣ The green filter (red free) allows easier differentiated of the nerve fiber layer, choroidal lesions, and retinal vasculature. A red free filter will cause a choroidal nevus to become more difficult to visualize or disappear
Scleral depression
◦ Indications: similar indications as a three mirror evaluation. Scleral depression allows oblique viewing of retinal tissue, which increases contrast and allows easier identification of abnormalities
◦ Scleral depression should NOT be performed on patients with recent intraocular surgery or patients with penetrating ocular injury, hyphema, or ruptured globe
Asteroid hyalosis
- epidemiology/Hx: associated with aging; occurs in 0.5% of the population over 60 years of age
- Symptoms: asymptomatic-does not interfere with vision or cause floaters
- Signs: numerous small, yellow-white, refractile particles (calcium phosphate soaps) attached to collagen fibrils in an essentially normal vitreous; unilateral in 75% of the cases
Synchysis scintillans
- pathophysiology/Dx: rare conditio nthat occurs after chronic uveitits, vitreous hemorrhage, and/or trauma
- Signs: unilateral, golden-brown, refractile cholesterol crystals that are freely mobile in the vitreous cavity (often settle inferiorly)
Who gets PVDs
more common in females. Prevalence appx age after 50 years old (50% in 50 year old, 60% in 60 year old, etc)
◦ PVDs occur an average of 20 years earlier in myopes than in emmetropes
◦ Other risk factors include diabetes, intraocular surgery, intraocular inflammation, vitreous hemorrhage, and trauma
Pathophysiology of PVD
the HA-collagen complex in the vitreous is disrupted with age, causing the collagen to clump up in bundles. Liberated collagen can contract within the complex, causing the posterior hyaloid to detach from the retina. Pockets of liquefaction (syneresis) can travel through the hole in the posterior hyaloid and cause separation between the vitreous and the retina. The PVD can be localized, partial, or total
Symptoms of PVD
acute onset floaters, flashes of light, and decreased vision
Photopsia in eyes with acute PVDs
Thought to result from traction at the site of the vitreoretinal adhesions
Signs of PVD
Weiss ring (black or grey ring shaped vitreous opacity over the optic nerve) and anteiror displacement of the posterior hyaloid; may also see vitreous pigment cells (tobacco dust/Shaffer sign) and a vitreous hemorrhage
Vitreous traction during a PVD
can result in ERM, macular holes, vVMT, vitreous and retinal hemorrhages, and retinal breaks. 10-15% of patients with an acute symptomatic PVD will have a retinal break; this risk increases 70% if a vitreous hemorrhage is present. Retinal pigment epithelium can be released into the vitreous (Shaffer’s sign) after a retinal tear, which can aid in the diagnosis
Epidemiology of preretinal/vitreous hemorrhage
ask about trauma and pertinent ocular and systemic diseases, especially DM and HTN
Pathophysiology of preretinal/vitreous hemorrhage
preretinal and victory’s hemorrhages result from trauma or from conditions that cause retinal neo. These include the following
◦ diabetic retinopathy, retinal vein occlusion, sickle cell retinopathy, ROP, and ocular ischemic syndrome
◦ In each of these cases, the neo is preretinal in location and the newly formed vessels lack endothelial tight junctions. The location (preretinal) and strength (leaky) of these vessels created a situation where vitreous traction can cause shearing of the vessels, resulting in hemorrhage formation
Symptoms of preretinal hemorrhage
usually does not cause symptoms unless it involves part of the macula (results in sudden loss of vision or part of the visual field)
Symptoms of vitreous hemorrhage
usually causes painless vision loss and/or black spots that can have corresponding flashing lights
Signs of preretinal hemorrhage
located between the retina and an intact posterior vitreous face; appears very red and often has a keel shape
Signs of a vitreous hemorrhage
located within the vitreous (anterior to the posterior vitreous face). A mild vitreous hemorrhage will be characterized by blood that obscures only part of the fundus. Severe hemorrhages will completely obscure the view of the fundus. Chronic cases will appear yellow
‣ A B scan is indicated if the fundus cannot be viewed throught the vitreous hemorrhage
Types of neo
Preretinal and chorodial
Preretinal neo
leads to preretinal or vitreous hemorrhage and/or tractional retinal detachement. Remember DR VOS for preretinal neo
Chorodial neo
within the subretinal space (CNVM) that results in a subretinal and/or subREP heme, pigment epithelial detachment, and serous retinal detachment. Remember CHBALA for choroidal neo
Epidemiology/Hx of CRVO
prevalence 0.1-0.4%. CRVOs are the 3rd most common vascular cause of vision loss (DR is the second most common). An estimated 7% of patients will have a CRVO in the fellow eye
Risk factors for CRVO
HTN, DM, cardiovascular disease, and open angle glaucoma
Glaucoma and CRVO
◦ Glaucoma is the ocular disease that is most commonly assocaited with CRVOs; up to 40-60% of patients with CRVO have POAG
CRVO in young patients
oral contraceptive pills, protein S/C/antithrombin III deficiency, factor XII deficiency, antiphospholipid Ab syndrome, collagen vascular disease, and AIDs
Pathophysiology/Dx of CRVO
result from compression of an artery on a vein; this leads to turbulent blood flow, venous vessel wall damage, and thrombus formation. CRVOs are usually caused by a thrombus at or near the lamina cribrosa
Symptoms of CRVO
characterized by a sudden, unilateral, painless visions loss in an elderly patient. (90% of patients with a CRVO are > 50 years old)
Signs of CRVO
thrombus formation leads to ischemia and release of VEGF which characteristic retinal findings including retinal hemorrhages in all 4 quadrants, collaterals, dilated torturous retinal veins, CWS, and optic disc edema
Collateral veins in CRVO
‣ Collateral veins become visible over several weeks to months; they are often on the disc and permit blood flow between the retina and chorodial circulations, helping to accelerate drainage of excessive fluid (Retinal edema) into the choroidal circulation after a CRVO
Vision threatening complications of CRVO
◦ Vision threatening complications include macular disease and complication from neo. VEGF stimulates neo of the posterior and anterior segment and has been prove to cause capillary leakage leading to macular edema
‣ 1. Macular disease-macular ischemia, macular edema, and intramacular hemes
‣ 2. Neo-neovascular glaucoma, preretinal/vitreous hemorrhage, and tractional RD
Neovascular glaucoma and CRVO
◦ Neovascular glaucoma is a major concern in patients with a CRVO and is most likely to develop within the 1st 3 months of Dx (90 day glaucoma). 60% of ischemic cases develop iris neo and up to 33% develop neo glaucoma. 6% of non ischemic cases develop rubeosis or angle neo
Leading cause of vision loss in both ischemic and non ischemic CRVO
Macular edema
Ischemic vs nonischemic CRVOs
‣ Ischemic CRVO is defined as 10 disc diameters or more of non-perfusion on FA. 90% of cases present with 20/200 vision or worse, and the prognosis is poor. 16% of nonischemic cases progress to ischemic CRVOs
Epidemiology of BRVO
BRVOs are by far the most common retinal vascular occlusive disease; patients have a similar health history as patients with CRVOs
Most common vascular occlusive disease
BRVO
Risk factors for BRVO
HTN, cardiovascular disease, increased body mass index at 20 years old, and open angle glaucoma
Pathophysiolgoy/Dx
BRVOs are usually caused by a thrombus after compression of an artery on a vein at an AV crossing. 60% occur at an AV crossing within the superior/temporal quadrant
BRVOs that do not occur at AV crossings
• BRVOs that do not occur at an AV crossing should be evaluated with vasculitis. Remember that retinal arteries and veins share a common adventitia at AV crossings; this allows a thickened artery to compress the vein
Symptoms of BRVO
BRVOs are characterized by sudden, unilateral, painless visual field loss, blurred vision or no symptoms (if the macula is spared)
Signs of BRVO
retinal signs occur in the area of the distribution of the occluded vessel and include dilated torturous retinal veins, CWS, collateral vessels, and intraretinal hemorrhages
Vision threatening complications of BRVO
◦ Vision threatening complications include macular disease and complications from neo
‣ 1. Macular disease-macular ischemia, macular edema, and intramacular hemorrhage
‣ 2. Neo complications-preretinal/vitreous hemorrhage
Epidemiology/Hx of CRAO
ask about transient loss of vision (amaurosis Fugax). Commonly occurs in elderly patients. Patietns have a 10% risk of CRAO occurring in the fellow eye
Risk factors for CRAO
HTN, DM, carotid occlusive disease, cardiac valve disease
CRAO in young patients
IV drug usage and BC
Pathophysiology/Dx of CRAO
CRAOs most commonly arise from heart and/or carotid artery emboli
‣ Calcific emboli-large dangerous emboli from calcified heart valves often located in the CRA near the optic nerve
‣ Carotid Emboli-smaller cholesterol plaques (hollenhorst plaques)
Worst kind of emboli
Calcific
Usually from heart valves
Things that can cause CRAO
◦ Although retinal emboli are by far the most common etiolgoy for arterial occlusions, there are several other culprits to consider, including GCA, acute elevation in IOP, collagen vascular diseases, IV drug use, oral BC, sickle cell disease, and syphilis
Symptoms of CRAO
acute, profound vision loss (often 20/400 or worse). Unless a cilioretinal artery is present to spare the macula. If VA is LP or worse, strongly consider an ophthalmic artery occlusion
Cilioretinal artery in CRAO
‣ A cilioretinal artery branches form the SPCAs of the choroid and allows the macula to remain functional in a CRAO. It is present in 15-30% of patients
Signs of CRAO
superficial whitening of the inner retinal layers (returns to the normal color after perfusion is restored but does not regain function!), narrowed arterial vasculature, a cherry red spot in the foveola, and an afferent pupillary defect r(secondary to optic disc pallor from orthograde degeneration of RGC axons). Hollenhurst plaques or other emboli are also noted in 20-40% of cases
Neo glaucoma and CRAO
Rare
Epidemiology/Hx of BRAO
similar risk factors to CRAOs
Pathophysiology/Dx of BRAO
90% of cases are caused bu retinal emboli (hollenhurst plaques (most common), calcium, fibrin, and platelet emboli)
Symptoms of BRAO
often asymptomatic; may complain of a VF defect or sudden unilateral painless vision loss if the area of occlusion is close to or involving the macula
Signs of BRAO
superficial whitening of the retina in the distribution of the affected vessels due to retinal infarction and edema; hollenhurst plaques or other emboli are found within the area of occlusion in 62% of cases. The edem and retinal whitening eventually resolves within weeks, but the retinal tissue remains non functional and the patient with have permanent VF defect
Myelinated nerve fibers
are congential, benign, white patches in the superficial retina with feathery edges that represent abnormally myelination of ganglion cell axons anterior the lamina cribrosa. Myelination follows the distribution of the axons, can obscure the retinal vessels, and is typically located near the optic nerve. Differential diagnosis include BRAO and CWS
Indications for a diabetic retinal exam for type I DM
Within 3-5 years of diagnosis
Indications for a diabetic retinal exam for type II DM
At the time of diagnosis
For patietns with no diabetic retinopathy, repeat exams every year
For patients with mild to moderate retinopathy, repeat exams every 6-12 months
For patietns with severe NODR or PDR, repeat examinations every 2-4 months
Leading cause of new cases of blindness in the US for adults 20-74
diabetic retinopathy
Most important risk factors for development of DR
Duration of disease
‣ Patients who are dx with DM before age 30 have a 2% risk per year for developing DR; after 7 years-50%, after 25 years-90% with have DR
Pathophysiology/Dx of DR
DR occurs because of a loss of pericytes and damage to the retinal capillary BM, resulting in a breakdown of the blood retinal barrier. DR can be divided into non proliferative DR (NPDR or background DR) and proliferative DR (PDR)
NPDR
Can be divided into mild, moderate, severe, and very severe
Mild NPDR risk of progression
5% in 1 year
Moderate NPDR risk of progression to PDR
15% in 1 year
Severe NPRD risk of progression to PDR
52% risk in 1 year
Risk of progression for very severe NPRD
75% in 1 year
When is the diagnosis of very severe NPDR made
When two or more criteria are met within the 4-2-1 rule
- Severe retinal hemorrhages in 4 quadrants
- Venous beading in 2 quadrants
- IRMA in 1 quadrant
The diagnosis of NPDR is made when
The patient meets one criteria from the 4-2-1 rule
- Severe retinal hemorrhages in 4 quadrants
- Venous beading in 2 quadrants
- IRMA in 1 quadrant
4-2-1 rule
- Severe retinal hemorrhages in 4 quadrants
- Venous beading in 2 quadrants
- IRMA in 1 quadrant
PDR
occurs in 5% of patients with DR and is diagnosed based on the presence of neovascularization. If left untreated, PDR can progress to devastating outcomes. Patients with PDR who are most at risk for visions loss have high risk characteristics (HRCs)
High risk characteristics of PDR
- Neovascularization of the disc (NVD) greater than 1/4 DD within 1DD of the optic nerve
- Any NVD or NVE with an associated vitreous or preretinal hemorrhage
Symptoms of PDR
patietns are often asymptomatic or May experience vision and metamorphopsia
Signs of PDR
although there are numerous signs of DR, the most important threats to vision include macular disease and neovascularization
Macular disease in PDR
Macular ischemia
Macular edema
Macualr ischemia in PDR
may look normal or thickened; a FA can be used to differentiate macular ischemia from macular edema (macular ischemia will appear as an enlarged fovea avascular zone (hypofluoresce))
Macular edema in PDR
it can occur at ant stage of DR. CSME is based not he following 3 criteria (based on the presence of retinal thickening within the fovea)
• A. Retinal thickening within 500um (1/3DD) of the fovea center
• B. Hard exudates within 500um of the fovea center with adjacent retinal thickening
• C. Retinal thickening of at least 1DD within 1DD of the fovea center
The patient only needs to have one of the three to be diagnosed with CSME
CSME in PDR
- A. Retinal thickening within 500um (1/3DD) of the fovea center
- B. Hard exudates within 500um of the fovea center with adjacent retinal thickening
- C. Retinal thickening of at least 1DD within 1DD of the fovea center
The patient only needs to have one of the three to be diagnosed with CSME
Neovascularization in PDR
Threats to vision from neo include the following
‣ 1. Preretinal/vitreous hemorrhages
‣ 2. Neovascular glaucoma
‣ 3. Tractional RD
Epidemiology/Hx of HTN retinopathy
60 million Americans over the age of 18 years of age have HTN; more prevalent in AA. Essential HTN accounts for 95% of all cases of HTN and is defined as elevated blood pressure with no known cause
Pathophysiology/dx of HTN retinopathy
recall that retinal arteries are able to auto regulate their vessel diameter based on changes in blood pressure; autoregulation is altered at extremely high or chonrically elevated systolic pressures and retinopathy results. Systemic blood pressure must typically be at least 140/110 for the latter stages of HR to occur
Symptoms of HTN retinopathy
commonly asymptomatic. Vision is typically unaffected unless vascular changes cause macular edema (macular star), papilledema, a serous retinal detachement, or a vein occlusion
Stages of HTN retinopathy
1-4, 4 being the worst
Stage 1 HTN retinopathy
mild to moderate diffuse narrowing of the retinal arteries (but no focal constriction)
Stage 2 HTN retinopathy
stage 1 plus focal constriction of the retinal vasculature (AV nicking) and exaggerating of the arterial light reflex
Stage 3 HTN retinopathy
stage 2 plus retinal hemorrhages, CWS, hard exudates (likely in a star configuration within the OPL radiating away from the fovea), and retinal edema
Stage 4 HTN retinopathy
stage 3 plus papilledema (malignant HTN). Patients with malignant HTN must be hospitalized immediately due to high risk of stroke. BP at this stages is usually 220/120.
HTN retinopathy is associated with numerous secondary conditions that can lead to vision loss, including
vascular occlusion, retinal macroaneurysms, NAION, ocular motor palsies, and worsening of DM.
Elschnig spots
choroidal infarcts that occur in severe HR
Epidemiology/Hx of retinal macroaneurysms
more common in elderly women (7th decade) with HTN or atherosclerosis
Symptoms of retinal artery macroaneurysms
usually asymptomatic, but can have gradual vision loss from macular edema or sudden vision loss from a vitreous hemorrhage
Signs of retinal artery macroaneurysms
unilateral focal area of dilation in a retinal artery (100-250um in diameter) with multi-level hemorrhages (subretinal, intraretinal, preretinal, and/or vitreous hemorrhage) from a ruptured aneurysm with surrounding circulate exudates; often located at an AV crossing
Description of the hemorrhages in retinal artery macroaneurysms
multi-level hemorrhages (subretinal, intraretinal, preretinal, and/or vitreous hemorrhage)
Epidemiology/Hx of venous stasis retinopathy?OIS
Men
Ages 50-80
Pathophysiology/Dx of venous stasis retinopathy/OIS
caused by occlusion of the ICA and/or ophthalmic artery (less common), usually secondary to atherosclerosis; may also occur as a result of GCA
Symptoms of venous stasis retinopathy/OIS
common symptoms include gradual vision loss, dull periorbital pain or HA, and amaurosis fugax
Signs of venous stasis retinopathy/OIS
unilateral (80%) dot/blot hemorrhages of the midperipheral fundus, dilated non-tortuous retinal veins, narrowed retinal arteries, and possible neo of the disc and/or anterior segment (67% of patients with OIS have NVI/NVA at the time of diagnosis)
Difference between OIS and venous stasis retinopathy
‣ If a patient has these retinal findings and carotid artery obstruction, but no anterior segment signs, the condition is called venous stasis retinopathy
‣ The presence of both posterior and anterior segment signs and symptoms is referred to as OIS. OIS is most common in male patients 50-70 years old
OIS is commonly associated with
systemic HTN, DM, and cardiac disease; the latter is most common cause of a 40% 5 year mortality rate in these patients
Amaurosis fugax
type of TIA characterized by transient monocular vision loss that typically lasts seconds to minutes; vision returns to normal after the ischemic event. A carotid artery embolus is the most common cause of amaurosis fugax
TIA vs stroke
characterized by temporal neurological defects due to transient loss of blood flow to the brain. Perfusion is always resorted in less than 24 hours (usually less than 15 minutes), resulting in complete resolution of the patient’s symptoms without any permanent damage. In contrast, a stroke is characterized by permanent neurological deficits due to prolonged loss of blood flows that results in irreversible damage to the brain
Things that cause pre retinal neo
Proliferative Neo DRVOS -DM -ROP -Vein occlusions -OIS -Sickle cell
What are the main problems with preretinal neo
Proliferative, DRVOS
- Preretinal/vit heme
- Tractional RD (vit pulls on neo)
- VEGF=NVG
Number one cause of all occlusions
- HTN
- Plaques from the heart
A clot that stays where it formed
Thrombus
Which causes vein occlusions, thrombus or embolus
Thrombus
Which causes artery occlusions, thrombus or embolus
Embolus
Why do we get thrombus
- HTN/DM (artery prob)
- Artery compressing vein
- Bad/turbulent blood flow
- Thrombus formed
- VEGF released
Which is worse, ischemic or non ischemic CRVOs
Ischemic
What layers of the retina are damage in CRAO
OPL-> ILM
VF loss in BRAO
Respects horizontal midline, Mimics glaucoma
5 most important things in DM
- Preretinal/vit heme
- Tract RD
- VEGF-NVG
- Ischemic macula
- Macular edema
Damage to pericytes in DM
- autoregulation problem
- ONH
- retinal vessels
Break down of BRB
- between RPE cells
- retinal BV
Swelling in ischemia
Ischemia is decreased O2, it initally swells and then thins
Primary HTN ret findings
Mac star (3 or 4) Papilledems (4)
Findings secondary to HTN (other than HTN retinopathy)
CRAO, BRAO, CRVO, BRVO NAION EOM palsy Worsening DM Macroaneurysms
Things that cause NAION
Viagra
Imitrix
Amiodarone
SPCA not doing its job
What should be ordered for someone with OIS
Carotid Doppler
Pathophysiology/Dx of hyperviscosity retinopathy
an increase in resistance to blood flow secondary to elevated levels of proteins, RBCs, and/or WBCs, resulting in impaired circulation of blood flow and oxygen though the microvasculature. As blood flow decreases, blood vessel walls become damaged, causing leakage of fluid and retinal ischemia
The most common cause hyperviscocity retinopathy
hyperglobulinemia, a condition found in Waldenstrom’s macroglobulinemia, multiple myeloma, serum positive RA, SLE, and HIV infection
Signs of hyperviscocity retinopathy
retinal venous dilation, retinal hemorrhages, CWS, and exudates. Central retinal vein occlusion may also occur and is bilateral in 10% of patients
HIV retinopathy
◦ The most common ocular manifestation of HIV/AIDS. Signs include CWS and retinal hemorrhages, similar appearance to DR and early CMV retinitis
◦ Patients are typically asymptomatic. The condition is non infectious in origin
Interferon retinopathy
◦ Patients on interferon therapy can develop retinal findings similar to DR, including CWS and retinal hemorrhages within the posterior pole.
◦ Retinopathy typically occurs within 3-5 months after interferon is started, and tends to resolve without treatment after interferon has been discontinued
How often should patients on interferon retinopathy be followed
◦ Patients on interferon therapy without retinopathy should be followed every 4-6 months; if retinopathy is present, follow ups should occur more frequently
Talc retinopathy
◦ Presents bilaterally in IV drug users who use talc as a filler
◦ The talc gets caught in the retinal capillaries and will appear as multiple, yellow, refractile, deposits that tends to be clustered near the macula
◦ The talc may cause capillary occlusion and retinal ischemia
Periphlebitis
Sarcoidosis
-lac gland, CN VII, OHN, vessels, vitreous
AA female
Hard exudates that leak
Vasculitis=inflammation
An inflammatory condition characterized by exudates around the vessels (seen as white cuffing of the vessels). Retinal edema, ischemia, and hemorrhaging may also occur. Vessel walls will stain on FA
Vascualr sheathing/periphlebitis
Most common causes of vascular sheathing/periphlebitis
syphilis, sarcoidosis (known as candle wax drippings), pars planitis, and sickle cell disease
Testing for vascular sheathing/periphlebitis
◦ Diagnostic systemic lab testing should be done based on the revive of systems and case history to determine the systemic cause of the vascular sheathing
Are bilateral retinoblastoma hereditary or non hereditary
All bilateral=hereditary
Are unilateral RBs hereditary or non
Most of them are nonhereditary
Pathophysiology/Dx of idiopathic juxtafoveolar telangiectasia
abnormal perifovea capillaries present within the juxtafoveal region. IJXT is divided into three categories
Unilateral congenital idiopathic juxtafoveolar retinal telangiectasia
occurs in men in the 4th decade; results in 20/25-20/40 vision
Unilateral idiopathic form of idiopathic juxtafoveolar retinal telangiectasia
occurs in middle aged men; reuslts in 20/25 or better acuity
Bilateral acquired form of idiopathic juxtafoveolar retinal telangiectasia
equal sex distribution in the 5th or 6th decade. Poor visual prognosis
Symptoms of idiopathic juxtafoveolar retinal telangiectasia
Decreased vision
Signs of idiopathic juxtafoveolar retinal telangiectasia
right angle venules and dilated tortuous vessels, hemes, varying degrees of exudates (moderate to none at all) within or nearby the fovea, macular edema, and/or CNVM
Epidemiology/Hx of Coat’s disease
peak incidence in males less than 20 years old; 2/3 of cases present prior to age 10. Progression is more rapid in children under 4 years old, simulating retinoblastoma
Pathophysiology of Coat’s disease
idiopathic peripheral vascular disease. If left untreated, coats disease will gradually progress to a total exudative RD
Symptoms of Coats
decreased vision, strab, leukocoria
Signs of Coats
unilateral, telangiectatic dilated vessels that display a characteristic “lightbulb” appearance. Progression of the disease can lead to marked hard exudates (classic for coats), intraretinal hemorrhagehs, exudative retinal detachement, and NVG (results in red painful eye and potentially blind eye)
How does Coats lead to NVG
A chronic extensive serous detachment in coats disease results in retinal ischemia, which leads to the development of anterior segment neovascularization similar in pathology to the DR VOS conditions. NVA and NVI result in NVG
Epidemiology/Hx of ROP
occurs in premature infants (less than 32 weeks) or low birth weight infants (<1500g) who have received oxygen therapy
Pathophysiology of ROP
immature blood vessels vasoconstriction and stop developing in response to high oxygen concentration, leading to proliferative retinopathy. Threatens to vision include preretinal/vitreous hemorrhages, and tractional RDs
Signs of ROP
leukocoria, strab, vitreoretinal traction, preretinal/vitreous hemorrhages, and tractional RDs
Leukocoria and ROP
white pupillary reflex that resutls from fibrovascular scarring secondary to a tractional RD in cases of ROP
Which part of the retina matures last?
The anterior temporal retina is the last area of the retina to achieve mature vascular development during the 9th month of gestation. This area is most susceptible to neovascularization and subsequent tractional RDs in pre term infants with ROP
Epidemiology/Hx of RB
the most common intraocular malignancy in kids and the second most common of all age groups (choroidal melanoma is the most common). 95% of cases are diagnosed by 5 years of age. No gender or race predilection
The smog common intraocular malignancy in kids
RB
The second most common intraocular malignancy in all age groups
choroidal melanoma
Pathophysiology/ Dx of RB
tumor derived from cells in the developing retina (retinoblasts) as a result of mutations in the Rb tumor suppressor gene
Heritable RB
40%
all bilateral cases and about 10-20% of unilateral cases. However, only 6% of these have a positive family Hx of the condition because the tumor has such a high spontaneous mutation rate. Bilateral affected patients have a 50% chance of passing the disease on to each offspring